Erasca to Present at Upcoming Conferences in November

Rhea-AI Summary

Erasca (Nasdaq: ERAS) announced management will participate in investor conferences and one-on-one meetings in November 2025. Events and times:

• Guggenheim 2nd Annual Healthcare Innovation Conference — Boston, Nov 10-12; Fireside chat on Nov 11 at 2:00 pm ET.
• Stifel 2025 Healthcare Conference — New York, Nov 11-13; Fireside chat on Nov 12 at 1:20 pm ET.
• Jefferies Global Healthcare Conference — London, Nov 17-20; Fireside chat on Nov 19 at 10:30 am GMT.

A live audio webcast will be available at Erasca.com/events, with archived replays accessible for 30 days after each webcast.

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences in November 2025 and will also participate in one-on-one investor meetings at each of these conferences.

Guggenheim 2nd Annual Healthcare Innovation Conference (November 10-12, 2025)
Location: Boston, MA
Format: Fireside Chat
Date and Time: Tuesday, November 11, 2:00 pm Eastern Time

Stifel 2025 Healthcare Conference (November 11-13, 2025)
Location: New York, NY
Format: Fireside Chat
Date and Time: Wednesday, November 12, 1:20 pm Eastern Time

Jefferies Global Healthcare Conference (November 17-20, 2025)
Location: London, UK
Format: Fireside Chat
Date and Time: Wednesday, November 19, 10:30 am Greenwich Mean Time

A live audio webcast of the events will be available online at Erasca.com/events. An archived replay of the events will be available for 30 days following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of patients with cancer. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

FAQ

When will Erasca present at the Guggenheim Healthcare Innovation Conference (ERAS)?

Erasca will present a fireside chat on November 11, 2025 at 2:00 pm ET in Boston.

What time is Erasca's presentation at the Stifel 2025 Healthcare Conference (ERAS)?

Erasca's fireside chat is scheduled for November 12, 2025 at 1:20 pm ET in New York.

When and where will Erasca speak at the Jefferies Global Healthcare Conference (ERAS)?

Erasca will present a fireside chat on November 19, 2025 at 10:30 am GMT in London.

Will Erasca provide a webcast of the November 2025 conference presentations (ERAS)?

Yes. A live audio webcast will be available at Erasca.com/events and archived for 30 days after the webcast.

Can investors request one-on-one meetings with Erasca management at the November 2025 conferences (ERAS)?

Yes. Management will participate in one-on-one investor meetings at each listed conference.